Skip to main content
Skip to main content
CI logo

Cigna Corporation (CI)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cigna Corporation (CI) trades at $263.47 with AI Score 43/100 (Weak). Cigna Corporation is a global health service company offering insurance and related products and services. Market cap: $70.38B, Sector: Healthcare.

Last analyzed: Feb 8, 2026
Cigna Corporation is a global health service company offering insurance and related products and services. The company operates through its Evernorth and Cigna Healthcare segments, providing a wide array of health solutions.
43/100 AI Score Target $332.62 (+26.2%) MCap $70.38B Vol 1.71M

Cigna Corporation (CI) Healthcare & Pipeline Overview

CEODavid Michael Cordani
Employees71295
HeadquartersBloomfield, CT, US
IPO Year1982

Cigna Corporation (CI) delivers integrated health solutions through its Evernorth and Cigna Healthcare segments, offering diverse medical, pharmacy, and behavioral health services; a notable research candidate driven by a focus on coordinated care and expanding its Medicare Advantage offerings, with a dividend yield of 2.07%.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Cigna Corporation presents a notable research candidate driven by its integrated healthcare model and strategic focus on expanding its Evernorth and Cigna Healthcare segments. With a P/E ratio of 13.04 and a dividend yield of 2.07%, the company offers a blend of value and income. Key value drivers include the growth of its Evernorth segment, which provides high-margin pharmacy and care management services, and the expansion of its Medicare Advantage offerings to capture a larger share of the senior healthcare market. Cigna's focus on coordinated care and digital health solutions positions it well to capitalize on the evolving healthcare landscape. The company's strong financial position, with a market cap of $78.01B, supports continued investment in growth initiatives and shareholder returns. Investors may want to evaluate Cigna for its potential to deliver sustainable earnings growth and long-term value.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $78.01B reflects Cigna's significant presence and stability in the healthcare sector.
  • P/E ratio of 13.04 suggests the company is reasonably valued compared to its earnings.
  • Dividend Yield of 2.07% provides an attractive income stream for investors.
  • Gross Margin of 9.5% indicates the profitability of Cigna's core services.
  • Beta of 0.28 suggests the stock is significantly less volatile than the overall market.

Competitors & Peers

Strengths

  • Diversified business model with strong presence in insurance and pharmacy benefits management.
  • Large and established customer base.
  • Integrated platform enabling coordinated care and cost savings.
  • Strong financial performance and cash flow generation.

Weaknesses

  • Exposure to regulatory changes and healthcare reform.
  • Dependence on government programs such as Medicare and Medicaid.
  • Intense competition in the healthcare industry.
  • Potential for rising healthcare costs to impact profitability.

Catalysts

  • Continued expansion of Evernorth services to drive revenue growth.
  • Growth in Medicare Advantage membership and market share.
  • Development and deployment of digital health solutions.
  • Strategic acquisitions to expand capabilities and market reach.

Risks

  • Regulatory changes impacting the healthcare industry.
  • Increased competition from other healthcare providers and insurers.
  • Rising healthcare costs and utilization rates.
  • Economic downturns impacting consumer spending on healthcare.

Growth Opportunities

  • Expansion of Evernorth Services: Cigna's Evernorth segment offers significant growth potential by expanding its pharmacy, benefits management, and care delivery services. The market for pharmacy benefit management is estimated to reach $600 billion by 2028. By leveraging its integrated platform and data analytics capabilities, Evernorth can capture a larger share of this market and drive revenue growth. Timeline: Ongoing.
  • Medicare Advantage Growth: Cigna has a substantial opportunity to grow its Medicare Advantage business by targeting the increasing senior population. The Medicare Advantage market is projected to reach $400 billion by 2027. By offering competitive plans and expanding its geographic footprint, Cigna can attract more members and increase its market share. Timeline: Ongoing.
  • Digital Health Solutions: Investing in digital health solutions, such as telehealth and remote monitoring, can improve patient outcomes and reduce costs. The digital health market is expected to reach $660 billion by 2025. Cigna can leverage its technology infrastructure and partnerships to develop innovative digital health offerings that enhance the customer experience and drive efficiency. Timeline: Ongoing.
  • International Expansion: Cigna can expand its international presence by targeting emerging markets with growing healthcare needs. The global health insurance market is projected to reach $2.8 trillion by 2028. By entering new markets and offering tailored insurance products, Cigna can diversify its revenue streams and increase its global market share. Timeline: Ongoing.
  • Strategic Acquisitions: Cigna can pursue strategic acquisitions to expand its capabilities and market reach. The healthcare industry is consolidating, and acquisitions can provide access to new technologies, customer segments, and geographic markets. By carefully evaluating potential targets and integrating acquired businesses, Cigna can accelerate its growth and enhance its competitive position. Timeline: Ongoing.

Opportunities

  • Expansion into new geographic markets.
  • Growth in Medicare Advantage and other government-sponsored programs.
  • Development of innovative digital health solutions.
  • Strategic acquisitions to expand capabilities and market reach.

Threats

  • Increasing competition from other healthcare providers and insurers.
  • Changes in government regulations and healthcare policy.
  • Rising healthcare costs and utilization rates.
  • Economic downturns impacting consumer spending on healthcare.

Competitive Advantages

  • Strong brand recognition and reputation in the healthcare industry.
  • Extensive network of healthcare providers and pharmacies.
  • Integrated platform combining insurance, pharmacy benefits management, and care delivery.
  • Significant scale and market share in key segments, like Medicare Advantage.

About CI

Founded in 1792 and headquartered in Bloomfield, Connecticut, The Cigna Group has evolved into a global health service leader. Initially focused on insurance, the company has expanded its offerings to include a comprehensive suite of health-related products and services. Cigna operates through two primary segments: Evernorth and Cigna Healthcare. The Evernorth segment provides coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions. This segment caters to health plans, employers, government organizations, and healthcare providers. Cigna Healthcare offers medical, pharmacy, behavioral health, dental, and vision products, alongside health advocacy programs. This segment serves insured and self-insured customers, provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans, and offers individual health insurance plans both on and off public exchanges. Furthermore, Cigna Healthcare extends its coverage internationally, providing healthcare benefits for mobile individuals and employees of multinational organizations. The company distributes its products through brokers, consultants, directly to employers, and via public and private exchanges. Cigna's commitment to innovation and customer-centric solutions positions it as a key player in the healthcare industry.

What They Do

  • Provides medical insurance plans to individuals and families.
  • Offers pharmacy benefits management services.
  • Delivers behavioral health services and support.
  • Provides dental and vision insurance plans.
  • Offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans.
  • Provides health care coverage in international markets.
  • Offers health advocacy programs to help customers navigate the healthcare system.

Business Model

  • Generates revenue through premiums from health insurance plans.
  • Earns fees from pharmacy benefits management services.
  • Receives payments for providing healthcare services through its network of providers.
  • Manages risk by diversifying its customer base and geographic footprint.

Industry Context

Cigna operates in the dynamic healthcare plans industry, which is characterized by increasing demand for coordinated care and cost-effective solutions. The industry is undergoing significant transformation driven by technological advancements, regulatory changes, and evolving consumer preferences. Cigna competes with major players like CVS, CNC, and smaller regional providers. The market is witnessing a shift towards value-based care models and personalized healthcare experiences. Cigna's integrated approach, combining pharmacy benefits management with healthcare services, positions it favorably in this competitive landscape. The global healthcare market is projected to continue growing, driven by aging populations and increasing prevalence of chronic diseases.

Key Customers

  • Individuals and families seeking health insurance coverage.
  • Employers offering health benefits to their employees.
  • Government organizations providing healthcare to their constituents.
  • Healthcare providers seeking to improve patient outcomes and reduce costs.
AI Confidence: 73% Updated: Feb 8, 2026

Financials

Chart & Info

Cigna Corporation (CI) stock price: $263.47 (+0.00, +0.00%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CI.

Price Targets

Consensus target: $332.62

MoonshotScore

43/100

What does this score mean?

The MoonshotScore rates CI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About CI (Healthcare)

What does Cigna Corporation do?

Cigna Corporation is a global health service company that provides a wide range of insurance and related products and services. The company operates through its Evernorth and Cigna Healthcare segments. Evernorth offers pharmacy benefits management, care delivery, and data analytics solutions to health plans and employers. Cigna Healthcare provides medical, dental, vision, and behavioral health insurance plans to individuals, families, and employers. Cigna's integrated approach aims to improve health outcomes, lower costs, and enhance the overall customer experience, positioning it as a key player in the evolving healthcare landscape.

Is CI stock worth researching?

CI stock presents a mixed outlook. The company's strong market position and integrated healthcare model offer growth potential, particularly in the Evernorth segment and Medicare Advantage. With a P/E ratio of 13.04 and a dividend yield of 2.07%, the stock offers value and income. However, investors may want to evaluate potential risks such as regulatory changes and rising healthcare costs. A balanced analysis of Cigna's growth prospects, financial metrics, and risk factors is crucial before making an investment decision. Further, the stock data is pending update, so current valuations may not be accurate.

What are the main risks for CI?

Cigna faces several key risks, including regulatory changes in the healthcare industry, which could impact its business model and profitability. Increased competition from other healthcare providers and insurers could also put pressure on pricing and market share. Rising healthcare costs and utilization rates pose a significant challenge, potentially impacting Cigna's ability to manage costs and maintain profitability. Economic downturns could lead to reduced consumer spending on healthcare, affecting Cigna's revenue and earnings. Careful monitoring of these risks is essential for investors.

What are the key factors to evaluate for CI?

Cigna Corporation (CI) currently holds an AI score of 43/100, indicating low score. The stock trades at a P/E of 12.7x, below the S&P 500 average (~20-25x), potentially signaling value. Analysts target $332.62 (+26% from $263.47). Key strength: Diversified business model with strong presence in insurance and pharmacy benefits management. Primary risk to monitor: Regulatory changes impacting the healthcare industry. This is not financial advice.

How frequently does CI data refresh on this page?

CI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CI's recent stock price performance?

Recent price movement in Cigna Corporation (CI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $332.62 implies 26% upside from here. Notable catalyst: Diversified business model with strong presence in insurance and pharmacy benefits management. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CI overvalued or undervalued right now?

Determining whether Cigna Corporation (CI) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 12.7. Analysts target $332.62 (+26% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CI?

Before investing in Cigna Corporation (CI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • The analysis is based on the provided data and current market conditions.
  • Future events and market changes may impact the accuracy of the information.
Data Sources

Popular Stocks